Clinical Trials
10 trialsNCT03267680 2025-04-13
IRX-2 Regimen in Treating Women With Cervical Squamous Intraepithelial Neoplasia 3 or Squamous Vulvar Intraepithelial Neoplasia 3
University of Southern California
Phase 2 Terminated
NCT02864147 2024-05-02
Treatment of High-Grade Pre-Neoplastic Cervical Lesions (CIN 2/3)
Yale University
Phase 2 Completed
NCT02481414 2023-12-18
A Clinical Trial of PepCan to Two Therapy Arms for Treating Cervical High-Grade Squamous Intraepithelial Lesions
University of Arkansas
Phase 2 Completed
NCT01928225 2020-06-24
Randomized, Double Blind Trial of the Quadrivalent HPV Vaccine to Improve Responses to LEEP Treatment of Cervical HSIL
University of Witwatersrand, South Africa
Phase 2 Completed
NCT00081263 2017-09-15
Celecoxib in Treating Patients With Cervical Intraepithelial Neoplasia
GOG Foundation
Phase 2 Completed
NCT01256424 2016-05-16
Dose-finding Study of Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) to Treat Cervical Neoplasia
Photocure
Phase 2 Completed
NCT01405768 2014-07-28
Buffered Lidocaine for Loop Electrosurgical Excision Procedures (LEEPs)
Washington University School of Medicine
Phase 2 Completed
NCT00708942 2013-04-24
Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) of Cervical Intraepithelial Neoplasia (CIN) Grade 1
Photocure
Phase 2 Terminated
NCT00285207 2010-10-11
Safety and Efficacy of A-007 Topical Gel in the Treatment of High-Grade Squamous Intraepithelial Lesions (HSIL) of the Cervix
Tigris Pharmaceuticals
Phase 2 Completed
NCT00190983 2009-11-20
A Trial for Patients With Advanced/Recurrent Cervical Cancer
Eli Lilly and Company
Phase 2 Completed